Skip to content

LifeStent® XL Vascular Stent System EX051703CSRecalls & reported problems

Bard Peripheral Vascular, Inc. · BARD® LIFESTENT® XL Vascular Stent System 5 mm x 170 mm (130 cm delivery catheter) · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04049519010496), received between Apr 17, 2018 and Apr 17, 2018 — classified as 1 injury.

The most frequently reported specific device problem is “Occlusion Within Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Occlusion Within Device1

Patient problems

  • Stenosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryApr 17, 2018Occlusion Within Device; Occlusion Within Device

    IT WAS REPORTED THROUGH THE RESULTS OF A CLINICAL TRIAL THAT APPROXIMATELY TWELVE MONTHS POST STENT PLACEMENT IN THE SUPERFICIAL FEMORAL ARTERY, FEMOROPOPLITEAL ARTERY DUPLEX DEMONSTRATED IN-STENT STENOSIS. THERE WAS NO CHANGE IN STENOSIS DURING THE TWENTY-FOUR MONTH FEMOROPOPLITEAL ARTERY DUPLEX SCAN. THERE WAS NO REPORTED INTERVENTION.

    Patient problems: Stenosis

    MAUDE report 7438396 ↗

Other STENT, SUPERFICIAL FEMORAL ARTERY devices

All STENT, SUPERFICIAL FEMORAL ARTERY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page